A Pathway for Esophageal Obstruction is Associated with Decreased Cost and Length-of-Stay. Issue 2 (June 2022)

• Record Type: Journal Article
• Authors: Klutts, Garrett N.; Tingquist, Nicholas D.; Pagteilan, John; Muesse, Jason L.; Sexton, Kevin W.; Marino, Katy; Steliga, Matthew A.
• Is Part Of: Foregut. Volume 2:Issue 2(2022)
• Page Start: 208
• Page End: 211
• Publication Date: 2022-06
• Subjects: esophageal cancer -- esophageal obstruction -- health economics; 616.3
• DOI: 10.1177/26345161221077256
• Languages: English
• ISSNs: 2634-5161

Abstract

Malignancy of the esophagus or mediastinum can present with obstruction. Our focus is to identify the most effective means of managing this population. Data was gathered from a single institution for patients admitted with esophageal obstruction. Patients were categorized based on admission to thoracic surgery or the hospitalist service. Primary end-points were hospital length-of-stay (LOS) and hospital cost. The mean LOS was 4.4 days when admitted to thoracic surgery versus 13.5 days when admitted to a hospitalist ( P = .0005). The mean overall cost was $43, 902 less per patient when admitted to thoracic surgery ($75 809 vs $31 907; P = .003).